News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99,528 Results
Type
Article (2945)
Company Profile (29)
Press Release (96554)
Section
Business (39472)
Career Advice (54)
Deals (6139)
Drug Delivery (5)
Drug Development (12423)
Employer Resources (9)
FDA (1857)
Job Trends (2159)
News (57961)
Policy (3577)
Tag
Academia (218)
Adcomms (1)
Allergies (21)
Alliances (5135)
ALS (12)
Alzheimer's disease (242)
Antibody-drug conjugate (ADC) (35)
Approvals (1955)
Artificial intelligence (31)
Autoimmune disease (9)
Automation (2)
Bankruptcy (26)
Best Places to Work (1987)
BIOSECURE Act (1)
Biosimilars (17)
Biotechnology (13)
Bladder cancer (25)
Brain cancer (3)
Breast cancer (98)
Cancer (708)
Cardiovascular disease (35)
Career advice (48)
Career pathing (2)
CAR-T (27)
CDC (1)
Cell therapy (80)
Cervical cancer (7)
Clinical research (11291)
Collaboration (143)
Compensation (60)
COVID-19 (279)
CRISPR (10)
C-suite (61)
Cystic fibrosis (25)
Data (1025)
Depression (15)
Diabetes (45)
Diagnostics (1100)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (20)
Drug pricing (5)
Drug shortages (1)
Duchenne muscular dystrophy (38)
Earnings (31529)
Editorial (4)
Employer branding (3)
Employer resources (10)
Events (12566)
Executive appointments (67)
FDA (2407)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (145)
Gene editing (17)
Generative AI (2)
Gene therapy (48)
GLP-1 (124)
Government (369)
Grass and pollen (1)
Guidances (266)
Healthcare (2669)
HIV (6)
Huntington's disease (1)
IgA nephropathy (18)
Immunology and inflammation (19)
Immuno-oncology (2)
Indications (14)
Infectious disease (310)
Inflammatory bowel disease (36)
Inflation Reduction Act (1)
Influenza (13)
Intellectual property (17)
Interviews (6)
IPO (4159)
IRA (3)
Job creations (279)
Job search strategy (43)
Kidney cancer (4)
Labor market (9)
Layoffs (42)
Legal (539)
Liver cancer (11)
Longevity (1)
Lung cancer (104)
Lymphoma (78)
Management (2)
Manufacturing (63)
MASH (27)
Medical device (2184)
Medtech (2187)
Mergers & acquisitions (2116)
Metabolic disorders (112)
Multiple sclerosis (38)
NASH (2)
Neurodegenerative disease (17)
Neuropsychiatric disorders (5)
Neuroscience (388)
NextGen: Class of 2025 (703)
Non-profit (283)
Now hiring (1)
Obesity (37)
Opinion (16)
Ovarian cancer (35)
Pain (21)
Pancreatic cancer (22)
Parkinson's disease (29)
Partnered (2)
Patents (34)
Patient recruitment (42)
Peanut (10)
People (4314)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase I (2789)
Phase II (4679)
Phase III (4520)
Pipeline (1147)
Policy (7)
Postmarket research (477)
Preclinical (901)
Press Release (1)
Prostate cancer (41)
Psychedelics (1)
Radiopharmaceuticals (49)
Rare diseases (85)
Real estate (581)
Recruiting (4)
Regulatory (3108)
Reports (17)
Research institute (228)
Resumes & cover letters (6)
Rett syndrome (1)
RNA editing (1)
RSV (13)
Schizophrenia (25)
Series A (21)
Series B (22)
Service/supplier (1)
Sickle cell disease (13)
Special edition (2)
Spinal muscular atrophy (17)
Startups (302)
Stomach cancer (3)
Supply chain (6)
Tariffs (1)
Vaccines (89)
Venture capital (4)
Weight loss (27)
Women's health (4)
Worklife (2)
Date
Last 7 days (128)
Last 30 days (404)
Last 365 days (5537)
2025 (4486)
2024 (6699)
2023 (7759)
2022 (8650)
2021 (9090)
2020 (7985)
2019 (7320)
2018 (5339)
2017 (5230)
2016 (3953)
2015 (5113)
2014 (3540)
2013 (2481)
2012 (3290)
2011 (3231)
2010 (2711)
Location
Africa (71)
Alabama (9)
Alaska (1)
Arizona (22)
Arkansas (2)
Asia (4985)
Australia (825)
California (1324)
Canada (387)
China (128)
Colorado (67)
Connecticut (59)
Delaware (62)
Europe (28479)
Florida (156)
Georgia (43)
Idaho (3)
Illinois (87)
India (10)
Indiana (125)
Japan (112)
Kansas (33)
Kentucky (13)
Louisiana (6)
Maine (17)
Maryland (217)
Massachusetts (1135)
Michigan (36)
Minnesota (133)
Missouri (16)
Montana (6)
Nebraska (4)
Nevada (16)
New Hampshire (19)
New Jersey (662)
New York (455)
North Carolina (214)
Northern California (674)
Ohio (38)
Pennsylvania (363)
Rhode Island (2)
South America (117)
South Carolina (4)
Southern California (492)
Tennessee (7)
Texas (172)
United States (5608)
Utah (71)
Virginia (15)
Washington D.C. (6)
Washington State (137)
Wisconsin (16)
99,528 Results for "44".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging disease targets
September 4, 2025
·
1 min read
Press Releases
Avidity Biosciences’ Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44
September 10, 2025
·
14 min read
Press Releases
Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society
October 7, 2025
·
5 min read
Press Releases
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
September 30, 2025
·
4 min read
Press Releases
Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026
October 14, 2025
·
5 min read
Press Releases
Radiopharmaceuticals Market Size Worth USD 14.44 Billion by 2034
June 23, 2025
·
1 min read
Press Releases
Alzheon Announces Peer-Reviewed Scientific Publication of Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in APOE4/4 Homozygous Individuals with Early Alzheimer’s Disease
October 15, 2025
·
12 min read
Press Releases
Gameto’s $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial
August 13, 2025
·
5 min read
Press Releases
Cell Line Development Market Grows to USD 6.44 Billion in 2025 Amid CRISPR, AI and Biosimilar Expansion
July 3, 2025
·
1 min read
Press Releases
Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping
July 23, 2025
·
10 min read
1 of 9,953
Next
